Universitätsklinikum Graz — Graz

Public research footprint of Universitätsklinikum Graz, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

STEMI - ST Elevation Myocardial Infarction · Post-polycythemia Vera Myelofibrosis · Alpha1-Antitrypsin Deficiency · Peripheral Arterial Disease

Recently updated registry entries

NCT02872987 — GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding… (Recruiting)
NCT04957719 — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction (Enrolling By Invitation)
NCT04603495 — Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Universitätsklinikum Graz?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.